{"name":"QuadMedicine","slug":"quadmedicine","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Forteo Inj.","genericName":"Forteo Inj.","slug":"forteo-inj","indication":"Other","status":"phase_1"},{"name":"TeriQ Patch","genericName":"TeriQ Patch","slug":"teriq-patch","indication":"Other","status":"phase_1"},{"name":"Teribone Inj.","genericName":"Teribone Inj.","slug":"teribone-inj","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Forteo Inj.","genericName":"Forteo Inj.","slug":"forteo-inj","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"TeriQ Patch","genericName":"TeriQ Patch","slug":"teriq-patch","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Teribone Inj.","genericName":"Teribone Inj.","slug":"teribone-inj","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE0wNmdyNFlOZ2YydjVaM0JQNnNzWk5wa3FIaC1scnY2MlJOTkdXOXRKaW9vbUt5alg1SFFFamV2LW9mZHpOV25GbjZ1YXJiT19uelc0Tm1fdmpMRGhlTDVTR2w1dGRodWYwOVk4NUlB?oc=5","date":"2026-01-21","type":"pipeline","source":"팜이데일리","summary":"NGeneBio Hits Upper Price Limit After Adopting LG AI Research Institute’s Solution[K-Bio Pulse] - 팜이데일리","headline":"NGeneBio Hits Upper Price Limit After Adopting LG AI Research Institute’s Solution[K-Bio Pulse] - 팜이데일리","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTFBkYlBLNVlpZ2RUWDJRX1k2aDh5bUV4OEpiUVQtdmRLc2RkRFlzSlVZcVVaSWtQVUFJREFOZjJxNHYtM3lHaUtFRjh1V3owQkV0QXhZZQ?oc=5","date":"2025-12-31","type":"pipeline","source":"동아사이언스","summary":"[Medical & Bio News] QuadMedicine to Lead Development of Microneedle Treatment for Osteoporosis - 동아사이언스","headline":"[Medical & Bio News] QuadMedicine to Lead Development of Microneedle Treatment for Osteoporosis - 동아사이언스","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9pbUJxTDJvMkV1cXZLN1YydDB3LTNqWjUzT2FYQnhpX053amxIUmFqN2NRUzJ2by1yQ3NwX1I1OG9jODVzS0NKSm5aQXhJMXFxTlBMUlRjWFFKUVRZd2J4MFZiVk1ZTU5JeDhXcHZB0gFyQVVfeXFMTVZHcXByemdzZXpIMFQzdWZVcHBZSjhJOVpGamhJSE4xZmxCaXAyRlRmQU84YXdSeDVxRENTWGxmN0tRMzJjMEEzOUxCNlNWVG1OTm9YeXo4cVRWU3pwZ3dWVmNWSWZ2Y0lHQUYyQU5GSkt3?oc=5","date":"2025-12-30","type":"trial","source":"koreabiomed.com","summary":"QuadMedicine and GSK expand microneedle vaccine partnership with new non-clinical trial - koreabiomed.com","headline":"QuadMedicine and GSK expand microneedle vaccine partnership with new non-clinical trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOaFJuN1ZWVkwzWFFWbXZpZ2ZlYUFLemJXNlJHWDRFWTdORVVHd1VBVVhGdy1wV3V6ZzgweFNpOTZDZWRBaUlvaUpMNFpFcC14TEZoWVpfRllYQm9PTFJZM3dzUFhaeEF6UTNaX2lJUGdXVnNlUDF4Q0o2bGFwN05OOdIBlAFBVV95cUxNcGtaMDJZMnZJMnJoV2VVU2poOGU4VjJSX3RLQU5reEJmeTNVS2FMVUlmTlIwd0xjVmR5djRCUWNRZ0cyNjM1WFgtVXVHb2FTYmpOdmdHY0l3ZldQalpfcVVuOXE3ZHJWMXRhem1wcmhTdEdCM2hWWmVZbUxKQlJvN21TUTdFRHBSbHQtNVFrS1RyeTB6?oc=5","date":"2025-12-01","type":"pipeline","source":"Chosunbiz","summary":"Baek Seung-gi announces QuadMedicine’s plan to commercialize microneedle CDMO in South Korea - CHOSUNBIZ - Chosunbiz","headline":"Baek Seung-gi announces QuadMedicine’s plan to commercialize microneedle CDMO in South Korea - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE05XzZlOTJOQkMxcVRpOFQxbTNoSi1TcjFPa1JUSy1iSVJydHR0RzBNRzZNZkpwUENHc1dFckVRVGx1Nl9KcHpYTEF0M3BKdGdlbC13?oc=5","date":"2025-09-29","type":"regulatory","source":"벤처스퀘어","summary":"Quad Medicine receives preliminary listing review approval and begins IPO process. - 벤처스퀘어","headline":"Quad Medicine receives preliminary listing review approval and begins IPO process. - 벤처스퀘어","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBXMmM2WXU4bUZ3OGc1RXRTV2YtTWFNT2FvWXVGaDZNSG83YTdUT0psYkRiOFFqaV9Fa2pjTW1USUR5bGh2MWtVN1g3UENZamdDcWZobGN1LUN2aUlDRFNv?oc=5","date":"2025-08-05","type":"pipeline","source":"동아비즈니스리뷰 | DBR","summary":"Quadmedicine Unveils Next-Gen Microneedle Drug Delivery Platform - 동아비즈니스리뷰 | DBR","headline":"Quadmedicine Unveils Next-Gen Microneedle Drug Delivery Platform - 동아비즈니스리뷰 | DBR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE00YWluMVRPbDhteTFzVVZwRmlsYUdEMlFyMGNlYXF1NnhUOW1ORGFhMTN4NWNYTGNCS3hnSlNZUEhEX1dOSVF0TThlU1Rsc19UczRSM3NFaFVLX2liN0dnYWZ6YWFib2lEY2tqZFN30gFyQVVfeXFMUG4yTTI1M3ljUWJLUVhsZFNzR0NXcmU0cHdkY2h4c2p0UTQzSWZHMTdwbHRGRTF1U2QwVUI3R3JBRW80NU1lVWtHcnowWXJOeElDQVBNcTJKOXFiUFBWYlFvejI4d0NyUG84Q3FGcGZLOXln?oc=5","date":"2023-10-04","type":"pipeline","source":"koreabiomed.com","summary":"Korean pharma firms vie to develop patch-type obesity drugs - koreabiomed.com","headline":"Korean pharma firms vie to develop patch-type obesity drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9vTlFoMWN2UnVUM0ZXbEtSVkM0WS1nVnZuU3VPQ1lLcmVJTWNqbzBoVTRleXdzS3ZTSjB5UG9QcWduR3A0NFRubEppdHNKRzd4MnY2cjdiakVHbm5GMk9hQndlYnc2aVpJc0cxRmRR?oc=5","date":"2021-05-13","type":"pipeline","source":"koreabiomed.com","summary":"[Startups to Watch] ‘QuadMedicine aims for microneedle vaccine patch with improved efficacy’ - koreabiomed.com","headline":"[Startups to Watch] ‘QuadMedicine aims for microneedle vaccine patch with improved efficacy’","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":3},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}